Meiji Seika Pharma Co., Ltd.

This study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against a standard treatment for complicated urinary tract infections and kidney infections in adults. About 614 participants took part to see if the new drugs work better or as well …